Xcell Therapeutics Inc. (KOSDAQ:373110)
South Korea · Delayed Price · Currency is KRW 1,529.00
+1.00 (0.07%)
At close: Feb 27, 2026
Xcell Therapeutics Market Cap
Xcell Therapeutics has a market cap or net worth of 26.44 billion as of February 27, 2026. Its market cap has decreased by -39.49% in one year.
Market Cap
26.44B
Enterprise Value
31.59B
Revenue
1.36B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,529.00
Market Cap Chart
Since July 15, 2024, Xcell Therapeutics's market cap has decreased from 90.22B to 26.44B, a decrease of -70.69%. That is a compound annual growth rate of -53.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 26.44B | -7.95% |
| Dec 30, 2025 | 28.73B | -35.28% |
| Dec 30, 2024 | 44.38B | -50.80% |
| Jul 15, 2024 | 90.22B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genexine | 198.75B |
| Macrogen | 191.89B |
| MedPacto | 188.86B |
| ENCell | 181.02B |
| iNtRON Biotechnology | 127.37B |
| CG Invites | 111.65B |
| IMB Dx | 109.76B |
| GeneOne Life Science | 103.26B |